GOLD Strategy Update 2023: Rationale and Clinical Implications in Indian Perspective
Loading...
Date
2023-03
Authors
Bhardwaj, M
Kashyap, S.
Journal Title
Journal ISSN
Volume Title
Publisher
Jaypee Brothers Medical Publishers Pvt. Ltd
Abstract
Chronic obstructive lung disease (COPD) is a major contributor to global disease burden with a huge socioeconomic impact. Global initiative for chronic obstructive lung disease (GOLD) strategy update 2023 is a step forward in the direction of evidence-based practice. Key topics like taxonomic classification, ABE grouping, single inhaler triple therapy, correct use of inhalers, etc. would have a positive impact on documentation and prescription practices in COPD management. The tobacco consumption habits are peculiar in India. There is a variation in prevalence estimates across diverse cultures. Non-smoking risk factors are important in Indian subcontinent especially in female and younger populations. We discuss the rationale of latest GOLD strategy update, its implications, and challenges in the management of COPD in Indian context.
Description
Keywords
ABE grouping, Chronic obstructive lung disease, Global initiative for chronic obstructive lung disease 2023
Citation
Bhardwaj M, Kashyap S.. GOLD Strategy Update 2023: Rationale and Clinical Implications in Indian Perspective. Indian Journal of Chest Diseases & Allied Sciences. 2023 Mar; 65(1): 22-26